Gen-Probe Acquisition Drives up Hologic's Q2 Revenues 30 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Hologic reported after the close of the market on Monday that its fiscal second-quarter revenues increased 30 percent year over year, driven by the inclusion of sales from its Gen-Probe business, which Hologic acquired at the end of July.

The Bedford, Mass.-based company brought in revenues of $612.7 million for the three months ended March 31, compared to $471.2 million a year ago, but it missed the average Wall Street estimate of $639.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.